Published in Am J Trop Med Hyg on December 01, 2001
Options for field diagnosis of human african trypanosomiasis. Clin Microbiol Rev (2005) 3.12
Fine-needle aspiration, an efficient sampling technique for bacteriological diagnosis of nonulcerative Buruli ulcer. J Clin Microbiol (2009) 1.34
Plasma neuronal specific enolase: a potential stage diagnostic marker in human African trypanosomiasis. Trans R Soc Trop Med Hyg (2014) 0.76
Validity, reliability and ease of use in the field of five rapid tests for the diagnosis of Plasmodium falciparum malaria in Uganda. Trans R Soc Trop Med Hyg (2002) 2.66
Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neurosci Lett (2001) 2.05
Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults. J Neurol (2005) 2.04
Rapid assessment of population size by area sampling in disaster situations. Disasters (2001) 1.88
Neurofilament light protein and glial fibrillary acidic protein as biological markers in MS. Neurology (2003) 1.85
CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus. Acta Neurol Scand (2007) 1.85
Molecular dipstick test for diagnosis of sleeping sickness. J Clin Microbiol (2006) 1.84
Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study. Eur J Neurol (2009) 1.64
Brain-specific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr (2001) 1.60
Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke (1995) 1.58
Review Article: cerebrospinal fluid in human African trypanosomiasis: a key to diagnosis, therapeutic decision and post-treatment follow-up. Trop Med Int Health (2005) 1.52
Intrathecal release of pro- and anti-inflammatory cytokines during stroke. Clin Exp Immunol (1997) 1.51
Low specificities of HIV diagnostic tests caused by Trypanosoma brucei gambiense sleeping sickness. J Clin Microbiol (2010) 1.49
Health and war in Congo-Brazzaville. Lancet (2000) 1.47
Brain specific proteins in posthaemorrhagic ventricular dilatation. Arch Dis Child Fetal Neonatal Ed (2001) 1.46
Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006. Euro Surveill (2006) 1.38
Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology (2006) 1.37
Single centrifugation of cerebrospinal fluid in a sealed pasteur pipette for simple, rapid and sensitive detection of trypanosomes. Trans R Soc Trop Med Hyg (2000) 1.35
Follow-up of Card Agglutination Trypanosomiasis Test (CATT) positive but apparently aparasitaemic individuals in Côte d'Ivoire: evidence for a complex and heterogeneous population. Trop Med Int Health (2000) 1.27
IgM quantification in the cerebrospinal fluid of sleeping sickness patients by a latex card agglutination test. Trop Med Int Health (2002) 1.25
Melarsoprol refractory T. b. gambiense from Omugo, north-western Uganda. Trop Med Int Health (2001) 1.25
Blood-cerebrospinal fluid barrier and intrathecal immunoglobulins compared to field diagnosis of central nervous system involvement in sleeping sickness. J Neurol Sci (2002) 1.22
Antiretroviral treatment reduces increased CSF neurofilament protein (NFL) in HIV-1 infection. Neurology (2007) 1.21
Aparasitemic serological suspects in Trypanosoma brucei gambiense human African trypanosomiasis: a potential human reservoir of parasites? Acta Trop (2006) 1.21
Comparison of different DNA preparation protocols for PCR diagnosis of Human African Trypanosomosis in Côte d'Ivoire. Acta Trop (2002) 1.21
Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome. J Neurol Sci (2005) 1.20
Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest. Resuscitation (2001) 1.20
Neurofilament protein in cerebrospinal fluid: a marker of white matter changes. J Neurosci Res (2001) 1.19
Universal PCR assays for the differential detection of all Old World Leishmania species. Eur J Clin Microbiol Infect Dis (2010) 1.18
Neurofilament and glial fibrillary acidic protein in multiple sclerosis. Neurology (2004) 1.17
Cerebrospinal fluid markers for Alzheimer's disease evaluated after acute ischemic stroke. J Alzheimers Dis (2000) 1.13
Stage determination and therapeutic decision in human African trypanosomiasis: value of polymerase chain reaction and immunoglobulin M quantification on the cerebrospinal fluid of sleeping sickness patients in Côte d'Ivoire. Trop Med Int Health (2003) 1.13
Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury. Acta Neurochir (Wien) (2008) 1.12
Increased levels of GFAP in the cerebrospinal fluid in three subtypes of genetically confirmed Alexander disease. Neuropediatrics (2005) 1.12
Interleukin (IL)-6, IL-8 and IL-10 in serum and CSF of Trypanosoma brucei gambiense sleeping sickness patients before and after treatment. Trans R Soc Trop Med Hyg (2002) 1.10
Picropodophyllin induces downregulation of the insulin-like growth factor 1 receptor: potential mechanistic involvement of Mdm2 and beta-arrestin1. Oncogene (2007) 1.10
Comparison of serological tests for Trypanosoma evansi natural infections in water buffaloes from north Vietnam. Vet Parasitol (2000) 1.09
Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype. Eur J Neurol (2007) 1.08
Cytoskeleton proteins in CSF distinguish frontotemporal dementia from AD. Neurology (2000) 1.07
The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa. Lancet Infect Dis (2003) 1.06
Glial fibrillary acidic protein is increased in the cerebrospinal fluid of preterm infants with abnormal neurological findings. Acta Paediatr (1996) 1.06
[Therapeutic failure of melarsoprol among patients treated for late stage T.b. gambiense human African trypanosomiasis in Uganda]. Bull Soc Pathol Exot (1999) 1.04
Towards saliva-based screening for sleeping sickness? Trop Med Int Health (2003) 1.02
Increased serum levels of the S-100 protein are associated with hypoxic brain damage after cardiac arrest. Stroke (1998) 1.01
S-100 protein in melanocytic tumors. An immunohistochemical investigation of benign and malignant melanocytic tumors and metastases of malignant melanoma and a characterization of the antigen in comparison to human brain. Acta Pathol Microbiol Immunol Scand A (1984) 1.00
Evaluation of CSF biomarkers for axonal and neuronal degeneration, gliosis, and beta-amyloid metabolism in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2001) 0.99
Evaluation of whole fresh blood and dried blood on filter paper discs in serological tests for Trypanosoma evansi in experimentally infected water buffaloes. Acta Trop (2002) 0.98
Markers of nerve tissue injury in the cerebrospinal fluid in patients with lumbar disc herniation and sciatica. Spine (Phila Pa 1976) (1999) 0.97
Intrathecal immune activation is associated with cerebrospinal fluid markers of neuronal destruction in AIDS patients. J Neuroimmunol (2000) 0.97
Human and rodent interferon-gamma as a growth factor for Trypanosoma brucei. Eur J Immunol (1996) 0.97
The efficacy of chloroquine for the treatment of acute, uncomplicated, Plasmodium falciparum malaria in Laos. Ann Trop Med Parasitol (2002) 0.95
[Detection of anti-Lassa antibodies in the Western Forest area of the Ivory Coast]. Med Trop (Mars) (2006) 0.94
How does Trypanosoma equiperdum fit into the Trypanozoon group? A cluster analysis by RAPD and multiplex-endonuclease genotyping approach. Parasitology (2003) 0.93
No evident neuronal damage after electroconvulsive therapy. Psychiatry Res (2000) 0.93
Serum levels of glial fibrillary acidic protein correlate to tumour volume of high-grade gliomas. Acta Neurol Scand (2007) 0.92
Detection of trypanosome-specific antibodies in saliva, towards non-invasive serological diagnosis of sleeping sickness. Trop Med Int Health (2006) 0.92
General expression of RoTat 1.2 variable antigen type in Trypanosoma evansi isolates from different origin. Vet Parasitol (2001) 0.92
CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus. Neurology (1998) 0.92
Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism and other neuropsychiatric disorders. Biol Psychiatry (1993) 0.91
[Management of cholera epidemics in a refugee camp]. Bull Soc Pathol Exot (2002) 0.91
Case management of a multidrug-resistant Shigella dysenteriae serotype 1 outbreak in a crisis context in Sierra Leone, 1999-2000. Trans R Soc Trop Med Hyg (2004) 0.91
A semi-quantitative ELISA for detection of Trypanosoma brucei gambiense specific antibodies in serum and cerebrospinal fluid of sleeping sickness patients. Acta Trop (1998) 0.91
Proteolytic activity of Streptococcus mutans (GS-5). Oral Surg Oral Med Oral Pathol (1976) 0.91
Charting methods to monitor the operational performance of ELISA method for the detection of antibodies against trypanosomes. Vet Parasitol (2001) 0.90
Glial fibrillary acidic protein: a potential biomarker for progression in multiple sclerosis. J Neurol (2011) 0.90
CSF -neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage. Neurosci Lett (2006) 0.89
Measles vaccine effectiveness in standard and early immunization strategies, Niger, 1995. Pediatr Infect Dis J (1998) 0.89
Increased blood-brain barrier permeability around cerebral stab wounds, aggravated by acute ethanol intoxication. Acta Neurol Scand (1977) 0.89
Evaluation of LATEX/T.b.gambiense for mass screening of Trypanosoma brucei gambiense sleeping sickness in Central Africa. Acta Trop (2003) 0.89
Comparative in vitro isolation of Trypanosoma theileri from cattle in Belgium. Vet Parasitol (2000) 0.89
Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear palsy and multiple-system atrophy compared with Parkinson's disease. Mov Disord (1998) 0.88
[Validity, cost and feasibility of the mAECT and CTC confirmation tests after diagnosis of African of sleeping sickness]. Trop Med Int Health (2006) 0.88
Mid-life adiposity factors relate to blood-brain barrier integrity in late life. J Intern Med (2007) 0.88
Cerebrospinal fluid markers of pathogenetic processes in vascular dementia, with special reference to the subcortical subtype. Alzheimer Dis Assoc Disord (2000) 0.87
Bradycardic response during submersion in infant swimming. Acta Paediatr (2002) 0.87
Immunocytochemical investigations on the presence of neuron-specific antibodies in the CSF of Parkinson's disease cases. Neurochem Res (1988) 0.87
Validation of a PCR-oligochromatography test for detection of Trypanozoon parasites in a multicenter collaborative trial. J Clin Microbiol (2007) 0.87
Documenting violence against refugees. Lancet (2001) 0.87
Intrathecal expression of proteins regulating apoptosis in acute stroke. Stroke (1999) 0.86
Comparison of operational criteria for treatment outcome in gambiense human African trypanosomiasis. Trop Med Int Health (2009) 0.86
Establishment of a panel of reference Trypanosoma evansi and Trypanosoma equiperdum strains for drug screening. Vet Parasitol (2007) 0.86
Key indicators for the monitoring and evaluation of control programmes of human African trypanosomiasis due to Trypanosoma brucei gambiense. Trop Med Int Health (1998) 0.85
Effectiveness of mass vaccination with WC/rBS cholera vaccine during an epidemic in Adjumani district, Uganda. Bull World Health Organ (1999) 0.85
Human African trypanosomiasis: a latex agglutination field test for quantifying IgM in cerebrospinal fluid. Bull World Health Organ (1998) 0.84
S-100 alpha-like immunoreactivity in tubules of rat kidney. A clue to the function of a "brain-specific" protein. J Histochem Cytochem (1985) 0.84
Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet (2005) 0.84
Apolipoprotein E polymorphism and gender difference in outcome after severe traumatic brain injury. Acta Anaesthesiol Scand (2008) 0.84
Recombinant RoTat 1.2 variable surface glycoprotein as antigen for diagnosis of Trypanosoma evansi in dromedary camels. Int J Parasitol (2005) 0.83
Ghibe river basin in Ethiopia: present situation of trypanocidal drug resistance in Trypanosoma congolense using tests in mice and PCR-RFLP. Vet Parasitol (2012) 0.83
[Human african trypanosomiasis: A history of its therapies and their failures]. Trop Med Int Health (2001) 0.83
Enhanced blood-brain barrier leakage to evans blue-labelled albumin after air embolism in ethanol-intoxicated rats. Acta Neuropathol (1977) 0.83
Glial fibrillary acidic protein in the cerebrospinal fluid: a possible indicator of prognosis in full-term asphyxiated newborn infants? Pediatr Res (1995) 0.83
Field evaluation of the CATT/Trypanosoma brucei gambiense on blood-impregnated filter papers for diagnosis of human African trypanosomiasis in southern Sudan. Trop Med Int Health (2002) 0.83
CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest. J Neurol Sci (2004) 0.82
The IOP-IOL. A probe into the eye. Acta Ophthalmol (Copenh) (1992) 0.82
Differential localization of "brain-specific" S-100 and its subunits in rat salivary glands. J Histochem Cytochem (1984) 0.82